Published in Nutr Rev on December 01, 2011
Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial. Cancer Prev Res (Phila) (2013) 0.87
Development of exchange lists for Mediterranean and Healthy Eating diets: implementation in an intervention trial. J Hum Nutr Diet (2013) 0.83
A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude mice. Cancer Invest (2013) 0.83
A community-based lifestyle and weight loss intervention promoting a Mediterranean-style diet pattern evaluated in the stroke belt of North Carolina: the Heart Healthy Lenoir Project. BMC Public Health (2016) 0.82
Effects of a Mediterranean Diet Intervention on Anti- and Pro-Inflammatory Eicosanoids, Epithelial Proliferation, and Nuclear Morphology in Biopsies of Normal Colon Tissue. Nutr Cancer (2015) 0.77
Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon Tissue. Nutr Cancer (2016) 0.75
Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med (2003) 11.58
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 10.20
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov (2008) 5.78
Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med (2006) 5.37
Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res (1995) 4.52
Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr (2010) 3.99
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia (2001) 3.73
Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med (2007) 3.58
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53
Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol (2008) 3.16
Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care (2010) 3.07
Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature (2005) 2.90
The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res (2009) 2.80
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res (1995) 2.74
A prospective study of diet quality and mortality in women. JAMA (2000) 2.52
Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther (1999) 2.28
New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci (2002) 2.18
The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem (1987) 2.13
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem (2007) 2.10
Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. J Nutr (2004) 2.00
Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ (2009) 1.97
Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr (2008) 1.97
Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat (2002) 1.95
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet (2003) 1.95
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93
Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch Intern Med (1998) 1.92
Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol (2008) 1.88
Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem (2003) 1.85
Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta (1998) 1.78
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut (2006) 1.77
The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer. Am J Clin Nutr (2010) 1.66
Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol (1997) 1.63
Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst (1997) 1.62
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer (2010) 1.61
Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis (1999) 1.60
Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids (2007) 1.59
Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J Lipid Res (2005) 1.59
Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst (2007) 1.57
Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des (2006) 1.54
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res (2008) 1.54
The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr (2005) 1.54
Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr (2007) 1.51
Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids. Biochim Biophys Acta (1992) 1.50
Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr (2001) 1.46
Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res (2008) 1.45
Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res (2002) 1.39
Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res (2001) 1.39
Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry (2000) 1.39
Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem Pharmacol (1999) 1.39
Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr (2007) 1.37
Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology (2005) 1.37
Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem (1999) 1.36
Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer (1980) 1.35
Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene (1999) 1.31
Diet quality and subsequent cancer incidence and mortality in a prospective cohort of women. Int J Epidemiol (2005) 1.30
Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics (2006) 1.30
Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol (1998) 1.30
Dietary fats, membrane phospholipids and obesity. J Nutr (1994) 1.26
Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem (2004) 1.26
A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr (2007) 1.26
Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer (2007) 1.26
Total fat intake modifies plasma fatty acid composition in humans. J Nutr (2001) 1.24
Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids. Am J Clin Nutr (1985) 1.23
Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.22
Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem (2009) 1.20
Aberrant crypt foci. Anticancer Res (2006) 1.19
Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3. Carcinogenesis (2007) 1.19
Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res (2003) 1.16
HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. Int J Cancer (2004) 1.16
Adherence to the Mediterranean diet, long-term weight change, and incident overweight or obesity: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr (2010) 1.14
Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann N Y Acad Sci (1994) 1.13
Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut (1987) 1.13
Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res (1997) 1.13
Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis (2006) 1.13
Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species. J Lipid Res (2010) 1.12
Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res (2004) 1.11
Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut (1994) 1.11
A Mediterranean dietary intervention in healthy American women changes plasma carotenoids and fatty acids in distinct clusters. Nutr Res (2009) 1.11
Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr (2002) 1.10
A large randomized individual and group intervention conducted by registered dietitians increased adherence to Mediterranean-type diets: the PREDIMED study. J Am Diet Assoc (2008) 1.10
Dietary patterns and risk of colorectal tumors: a cohort of French women of the National Education System (E3N). Am J Epidemiol (2006) 1.10
Phospholipase A2 in eicosanoid generation. Am J Respir Crit Care Med (2000) 1.10
Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot Essent Fatty Acids (2010) 1.09
Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene. Food Chem Toxicol (2000) 1.08
Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut (1996) 1.08
Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res (1998) 1.08
Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol (2010) 1.06
Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase. J Biol Chem (1985) 1.06
Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells. Med Hypotheses (2005) 1.06
Localization, function and regulation of the two intestinal fatty acid-binding protein types. Histochem Cell Biol (2009) 1.04
Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J Proteome Res (2008) 1.04
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta (1996) 1.03
Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J Lipid Res (2004) 1.02
Transcending reductionism in nutrition research. Am J Clin Nutr (2003) 1.02
Mediterranean diet and cancer. Public Health Nutr (2004) 1.02
Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid membranes by different mechanisms. J Lipid Res (2000) 1.00
A pilot trial of spirituality counseling for weight loss maintenance in African American breast cancer survivors. J Natl Med Assoc (2009) 1.09